Jay L. Vivian

Jay L. Vivian

Auto-generated profile, based on publicly available information

Jay L. Vivian

Division of Clinical Genetics, Department of Pediatrics, Children’s Mercy, Kansas City, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in Cells
Verified
Journal Article
Open access
PDF file
PAPrashanth Anamthathmakula
Prashanth Anamthathmakula
PSPhilemon Shallie
Philemon Shallie
NNNeha Nayak
Neha Nayak
SDSabita Dhal
Sabita Dhal
JVJay L. Vivian
Jay L. Vivian
Nihar R NayakNihar R Nayak
Nihar R Nayak
The aromatase-Cre recombinase (Cyp19-Cre) transgenic mouse model has been extensively used for placenta-specific gene inactivation. In a pilot study, we observed unexpected phenotypes using this mouse strain, which prompted an extensive characterization of Cyp19-Cre placental phenotypes using ROSAmT/mG transgenic reporter mice. The two strains were mated to generate bi-transgenic Cyp19-Cre;ROSAmT/mG mice following a standard transgenic breeding scheme, and placental and fetal tissues were analyzed on embryonic day 17.5. Both maternal and paternal Cre inheritance were analyzed by mating the respective Cyp19-Cre and ROSAmT/mG males and females. The genotype results showed the expected percentage of Cyp19-Cre;ROSAmT/mG fetuses (73%) and Cre mRNA was expressed in all of the Cyp19-Cre placentas. However, surprisingly, only about 50% of the Cyp19-Cre;ROSAmT/mG placentas showed Cre-mediated recombinase activity as demonstrated by placental enhanced green fluorescent protein (EGFP) expression. Further genetic excision analysis of the placentas revealed consistent results showing the absence of excision of the tdTomato in all of the Cyp19-Cre;ROSAmT/mG placentas lacking EGFP expression. Moreover, among the EGFP-expressing placentas, there was wide variability in recombination efficiency, even in placentas from the same litter, leading to a mosaic pattern of EGFP expression in different zones and cell types of the placentas. In addition, we observed a significantly higher percentage of Cre recombination activity in placentas with maternal Cre inheritance. Our results show frequent mosaicism, inconsistent recombination activity, and parent-of-origin effects in placentas from Cyp19-Cre;ROSAmT/mG mice, suggesting that tail-biopsy genotype results may not necessarily indicate the excision of floxed genes in Cyp19-Cre positive placentas. Thus, placenta-specific mutagenesis studies using the Cyp19-Cre model require extensive characterization and careful interpretation of the placental phenotypes for each floxed allele.

15 January 2024 in Development
Verified
Journal Article
Open access
PDF file
KIKhursheed Iqbal
Khursheed Iqbal
EDEsteban M. Dominguez
Esteban M. Dominguez
BNBrandon Nixon
Brandon Nixon
AMAyelen Moreno-Irusta
Ayelen Moreno-Irusta
BCBenjamin Crnkovich
Benjamin Crnkovich
MSMichael J. Soares
Michael J. Soares
Placental development involves coordinated expansion and differentiation of trophoblast cell lineages possessing specialized functions. Among the differentiated trophoblast cell lineages are invasive trophoblast cells, which exit the placenta and invade the uterus, where they restructure the uterine parenchyma and facilitate remodeling of uterine spiral arteries. The rat exhibits deep intrauterine trophoblast cell invasion, a feature shared with human placentation, and is also amenable to gene manipulation using genome-editing techniques. In this investigation, we generated a conditional rat model targeting the invasive trophoblast cell lineage. Prolactin family 7, subfamily b, member 1 (Prl7b1) is uniquely and abundantly expressed in the rat invasive trophoblast cell lineage. Disruption of Prl7b1 did not adversely affect placental development. We demonstrated that the Prl7b1 locus could be effectively used to drive the expression of Cre recombinase in invasive trophoblast cells. Our rat model represents a new tool for investigating candidate genes contributing to the regulation of invasive trophoblast cells and their roles in trophoblast-guided uterine spiral artery remodeling.

30 January 2026 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
BTBradley T. Thornton
Bradley T. Thornton
AHAlexandra G. Hardinger
Alexandra G. Hardinger
LPLaramie Pence
Laramie Pence
PKPriyanka Prem Kumar
Priyanka Prem Kumar
NCNikolas Connolly
Nikolas Connolly
JVJay L. Vivian
Jay L. Vivian
Vici syndrome (VS) is a rare pediatric genetic disorder characterized by profound developmental delay, seizures, immune deficits, cardiomyopathy and progressive motor dysfunction. This devastating condition is caused by pathogenic variants in the EPG5 gene, which encodes a regulator of autophagy, leading to the accumulation of toxic intracellular material and widespread cellular dysfunction. Less-severe EPG5 pathogenic variants have recently been linked to rare familial forms of Parkinson’s disease, suggesting deficits in EPG5 function drive a range of neurodegenerative disorders. Currently, there are no effective treatments for any disorders associated with pathogenic variants of EPG5 . The underlying cellular mechanisms driving the progressive neurological decline in VS remain poorly understood. Previous studies using Epg5 knockout models have demonstrated severe neurological phenotypes; however, these models have not been characterized for molecular and cellular deficits within the central nervous system. Here we report the generation and analysis of novel genetically engineered mice with mutations in Epg5 as models of VS, including a strain harboring a truncating mutation that recapitulates a patient-derived pathogenic variant and a strain with an Epg5 null allele. These novel Epg5 mutant mouse models exhibited partial perinatal lethality. Neurological deficits of surviving were detectable by 6 weeks of age, and worsen over time. Histological analysis revealed widespread expansion of microglia and astrocytes throughout the central nervous system. Transcriptomic profiling of central nervous system tissue revealed robust neuroinflammatory signatures, sharing molecular profiles with disease-associated microglia observed in other models of neurological disease and injury. The analysis of these novel mouse models of VS suggest a critical role for neuroglial activation in the pathogenesis of VS. These novel in vivo models will be an essential platform for preclinical evaluation of therapeutics that target autophagy-related neurodegeneration in congenital disorders of autophagy and EPG5-associated neurodegeneration.

1 January 2004
Verified
Book Chapter
Closed access
PDF file
RARussell C. Addis
Russell C. Addis
BABruce Alberts
Bruce Alberts
MAMichal Amit
Michal Amit
PAPeter W. Andrews
Peter W. Andrews
HAHitomi Aoki
Hitomi Aoki
Robert ZweigerdtRobert Zweigerdt
Robert Zweigerdt

21 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
BTBradley T. Thornton
Bradley T. Thornton
AHAlexandra G. Hardinger
Alexandra G. Hardinger
LPLaramie Pence
Laramie Pence
PKPriyanka Prem Kumar
Priyanka Prem Kumar
NCNikolas Connolly
Nikolas Connolly
JVJay L. Vivian
Jay L. Vivian
Vici syndrome (VS) is a rare pediatric genetic disorder characterized by profound developmental delay, seizures, immune deficits, cardiomyopathy, and progressive motor dysfunction. This devastating condition is caused by pathogenic variants in the EPG5 gene, which encodes a regulator of autophagy, leading to the accumulation of toxic intracellular material and widespread cellular dysfunction. There are no effective treatments for disorders associated with pathogenic variants of EPG5. The underlying mechanisms driving the progressive neurological decline in VS remain poorly understood. Previous studies using Epg5 knockout models have demonstrated severe neurological phenotypes; however these models have not been characterized for molecular and cellular deficits within the central nervous system. We report the generation and analysis of novel genetically engineered mice with mutations in Epg5 , including a strain harboring a truncating mutation that recapitulates a VS patient-derived pathogenic variant and a strain with an Epg5 null allele. These novel Epg5 mutant mouse models exhibited partial perinatal lethality. Neurological deficits of surviving were detectable by six weeks of age, which worsen over time. Histological analysis revealed widespread expansion of microglia and astrocytes throughout the CNS. Transcriptomic profiling of CNS tissue revealed robust neuroinflammatory signatures, sharing molecular profiles with disease-associated microglia observed in other models of neurological disease and injury. The analysis of these novel mouse models of Vici syndrome suggest a critical role for neuroglial activation in the pathogenesis of VS. These novel in vivo models will be an essential platform for preclinical evaluation of therapeutics that target autophagy-related neurodegeneration in congenital disorders of autophagy.

5 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KIKhursheed Iqbal
Khursheed Iqbal
BNBrandon Nixon
Brandon Nixon
BCBenjamin Crnkovich
Benjamin Crnkovich
EDEsteban M. Dominguez
Esteban M. Dominguez
AMAyelen Moreno-Irusta
Ayelen Moreno-Irusta
MSMichael J. Soares
Michael J. Soares
Placental development involves coordinated expansion and differentiation of trophoblast cell lineages possessing specialized functions. Among the differentiated trophoblast cell lineages are invasive trophoblast cells, which exit the placenta and invade into the uterus where they restructure the uterine parenchyma and facilitate remodeling of uterine spiral arteries. The rat exhibits deep intrauterine trophoblast cell invasion, a feature shared with human placentation, and is also amenable to gene manipulation using genome editing techniques. In this investigation, we generated a conditional rat model targeting the invasive trophoblast cell lineage. Prolactin family 7, subfamily b, member 1 ( Prl7b1 ) is uniquely and abundantly expressed in the rat invasive trophoblast cell lineage. Disruption of Prl7b1 did not adversely affect placental development. We demonstrated that the Prl7b1 locus could be effectively used to drive the expression of Cre recombinase in invasive trophoblast cells. Our rat model represents a new tool for investigating candidate genes contributing to the regulation of invasive trophoblast cells and their contributions to trophoblast-guided uterine spiral artery remodeling.